Inkef
Inkef focuses on early-stage venture investing in European companies active in technology and healthcare.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Inkef Information
Geographic Data
Address: Gustav Mahlerplein 104
City: Amsterdam
State: noord-holland
Zip: 1082 MA
Country: NL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
6,111,536Website Global Rank
1,214Website Monthly Traffic
Twitter Followers
Description
Inkef is a venture capital firm based in Amsterdam, backing promising early stage companies in Europe. Inkef takes pride in being a patient, long-term investor with the ability to support companies through several rounds of funding. From the early stages of a technology or life science venture, Inkef supports entrepreneurs building their ideas into successful international businesses. Investment areas: Technology and Healthcare
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2012 | Lanthio Pharma | Series A | 6.2M |
| 10/2019 | EclecticIQ | Corporate Round | 7.6M |
| 5/2020 | QurAlis | Series A | 0 |
| 1/2019 | Polarsteps | Series A | 3.4M |
| 5/2016 | EclecticIQ | Series A | 6.3M |
| 1/2022 | AmbAgon Therapeutics | Series A | 0 |
| 3/2018 | NMD Pharma | Series A | 47M |
| 7/2015 | Shapeways | Series D | 30M |
| 8/2011 | ProFibrix | Series B | 10.6M |
| 3/2019 | Withlocals | Series B | 9M |
| 10/2020 | Silverflow | Seed Round | 3.1M |
| 11/2020 | EclecticIQ | Series C | 0 |
| 1/2019 | GeoPhy | Series B | 33M |
| 6/2021 | Sentinels | Seed Round | 0 |
| 3/2022 | ChannelEngine | Series B | 0 |
| 12/2021 | Silverflow | Series A | 17M |
| 7/2020 | ViCentra | Venture Round | 0 |
| 2/2021 | Lengoo | Series B | 20M |
| 3/2023 | QurAlis | Series B | 0 |
| 4/2018 | Shapeways | Series E | 30M |
| 2/2017 | Bloomon | Series B | 23M |
| 7/2022 | Baserow | Seed Round | 0 |
| 2/2022 | NMD Pharma | Venture Round | 0 |
| 3/2022 | Precirix | Series B | 0 |
| 4/2021 | Onward | Venture Round | 0 |
| 7/2020 | VarmX | Series B | 36.3M |
| 2/2023 | Quantum Motion | Series B | 0 |
| 5/2020 | Quantum Motion Technologies | Series A | 9.8M |
| 4/2020 | Remote | Seed Round | 11M |
| 4/2017 | Blendle | Series A | - |
| 9/2015 | Bloomon | Series A | 3.9M |
| 5/2016 | GeoPhy | Series A | - |
| 8/2021 | Cardior Pharmaceuticals | Series B | 0 |
| 4/2021 | Anavo Therapeutics | Seed Round | 0 |
| 2/2019 | Calypso Biotech | Series A | 22.7M |
| 9/2021 | Calypso Biotech | Series A | 0 |
| 1/2016 | ViCentra | Series B | 10.9M |
| 6/2021 | Urban Sports Club | Venture Round | 95.2M |
| 10/2019 | Draupnir Bio | Venture Round | 33M |
| 2/2016 | Crowdynews | Series A | 4.2M |
| 7/2022 | Happeo | Series B | 0 |
| 1/2020 | iOnctura | Series A | 16.6M |
| 6/2017 | Scenic Biotech | Series A | 7.3M |
| 10/2017 | Withlocals | Series A | 4.2M |
| 1/2015 | Crowdynews | Series A | 3M |
| 9/2021 | Shapeways | Post-IPO Equity | 0 |
| 2/2013 | Sapiens Steering Brain Stimulation | Series B | 9.8M |
| 8/2020 | Castor | Series A | 12M |
| 5/2014 | NPEX | Venture Round | - |
| 6/2012 | NPEX | Series A | 3.4M |
| 11/2011 | Robin Radar Systems | Series A | - |
| 5/2018 | OneFit | Series A | 5.1M |
| 6/2014 | Aito | Series B | 2.7M |
| 1/2021 | ChannelEngine | Series A | 0 |
| 12/2017 | Health Value Creation | Series A | 0 |
| 7/2018 | Castor | Seed Round | 6.3M |
| 7/2021 | Castor | Series B | 45M |
| 5/2020 | Happeo | Series A | 12M |
| 7/2016 | Nightbalance | Series B | 0 |
| 12/2015 | InteRNA Technologies | Series A | 0 |
| 10/2019 | Cashforce | Series A | 5.5M |
| 7/2020 | iOnctura | Series A | 5.8M |
| 9/2015 | Audion Therapeutics | Grant | 6.5M |
| 9/2020 | Salvia BioElectronics | Series A | 0 |
| 3/2013 | ViCentra | Series A | - |
| 3/2022 | Scenic Biotech | Series A | 0 |
| 6/2014 | Aito | Series B | 0 |
| 2/2019 | Aidence | Series A | 0 |
| 2/2022 | TargED Biopharmaceuticals | Series A | 0 |
| 8/2019 | Urban Sports Club | Venture Round | - |
| 4/2013 | Shapeways | Series C | 30M |
| 6/2019 | Comet Therapeutics | Series A | 28.5M |
| 1/2016 | Wercker | Series A | 4.5M |
| 12/2021 | ViCentra | Series C | 0 |
| 5/2018 | Rainier Therapeutics | Series B | 20M |
| 4/2016 | Onward | Series A | 29.5M |
| 7/2022 | Happeo | Series B | 0 |
| 7/2022 | Baserow | Seed Round | 0 |
| 3/2022 | Precirix | Series B | 0 |
| 3/2022 | ChannelEngine | Series B | 0 |
| 3/2022 | Scenic Biotech | Series A | 0 |
| 2/2022 | TargED Biopharmaceuticals | Series A | 0 |
| 2/2022 | NMD Pharma | Venture Round | 0 |
| 1/2022 | AmbAgon Therapeutics | Series A | 0 |
| 12/2021 | ViCentra | Series C | 0 |
| 12/2021 | Silverflow | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
